Completed PHASE3 INTERVENTIONAL NCT00446017

The Effects of Adrenaline and Milrinone in Patients With Myocardial Dysfunction After CABG (AMORI)

Phase 3 Study of Adrenaline and Milrinone in Patients With Myocardial Dysfunction

Sponsor: Deutsche Stiftung für Herzforschung

Updated 5 times since 2017 Last updated: Jun 2, 2015 Started: Jun 30, 2003 Primary completion: Aug 31, 2004 Completion: Apr 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Cardiac Output, Low, this trial is completed. The trial is conducted by Deutsche Stiftung für Herzforschung and has accumulated 5 data snapshots since 2003. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Deutsche Stiftung für Herzforschung
University of Luebeck

Data source: University of Luebeck

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.